🔗 Share this article

A shadow market for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on communication apps, according to new investigations.

Investigational Drug Gaining Traction Online

The experimental drug, which remains in research studies, is being promoted by online personalities for its alleged fat-burning properties. Followers are urged to contact these accounts privately for supplier links, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Separately, a flourishing market exists on Telegram, where groups with thousands of members share “before and after” images, injection guides and assertions of rapid British shipping. Sellers promote the substance there before redirecting buyers to other platforms for purchases.

Understanding Retatrutide

This medication is an experimental injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could help individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.

Medical Professionals Voice Concerns

However, doctors and pharmacists have cautions that the sale of what remains an unapproved medication in the UK is a cause for concern and could lead to users administering products of unknown origin.

Some professionals said the demand for retatrutide could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach medicines, advertising, and customer laws, potentially leading to penalties, prosecution or imprisonment.

Service Response and Content Elimination

According to the social media company, the service has removed problematic material and banned related keywords and search suggestions. The organization stated it was committed to keeping the platform secure and allocating resources in strengthening enforcement strategies.

Online Marketplace Activities

Research also discovered communities with up to nine thousand participants marketing the experimental drug using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” instantly displays channels with numerous of members, filled with images of slimming results, positive reviews and step-by-step guides for mixing or injecting at home.

After moments of entering one group, a seller posted WhatsApp details, where the majority of transactions take place. The vendor provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or past usage.

Item Information and Pricing

Within these groups, messages show dark colored packages with postal service stickers, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with purified liquid, or pre-filled pens typically sold at 160 pounds for 20mg. When questioned how much time a injector should last, sellers give conflicting answers varying between a several days to “depends on your body”.

Platform Oversight and Safety Measures

A representative for the messaging service stated it regularly moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are administering materials they can’t verify. Although the research behind this drug is valid, these digital products may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in interest to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, patients are turning to social media. But counterfeit injections are highly risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.

Her team has already encountered patients injured by personal administration from unverified sources. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is gambling with your health,” stated the doctor. “These substances could be impure or improperly measured.”

Producer Position

A spokesperson from Eli Lilly stated the substance was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may subject patients to possibly significant medical dangers”.